Perrigo loses High Court bid to overturn €1.64bn tax assessment

Tablets of over-the-counter allergy medicines, manufactured by Perrigo Co. 

Drug company Perrigo has lost its High Court action aimed at overturning a €1.64 billion tax assessment.

Mr Justice Denis McDonald concluded in a 155-page judgment today that Perrigo had failed to establish any basis for the court to interfere with the assessment, issued in respect of the disposal of the Tysabri IP and accordingly, its claim must be dismissed.